When Depression Complicates Childbearing: Guidelines for Screening and Treatment During Antenatal and Postpartum Obstetric Care

Obstetrics and Gynecology Clinics of North America

Volumn 36, Issue 4, 2009, Pages 771-788

  Muzik, Maria ^a   Marcus, Sheila M ^b   Heringhausen, Julie E ^c   Flynn, Heather ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Depression; Infant outcomes; Medication; Obstetric care; Peripartum; Psychotherapy

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DIPHENHYDRAMINE; DOCOSAHEXAENOIC ACID; DOXEPIN; ESTRADIOL; FLUOXETINE; ICOSAPENTAENOIC ACID; LITHIUM; LORAZEPAM; MIRTAZAPINE; MOOD STABILIZER; NEFAZODONE; NORETHISTERONE ENANTATE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADAPTATION SYNDROME; ALTERNATIVE MEDICINE; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG MILK LEVEL; EXERCISE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR DEPRESSION; MATERNAL SMOKING; NEONATAL ADAPTATION SYNDROME; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN INTENSIVE CARE; NUTRITIONAL COUNSELING; OBSTETRIC CARE; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; REVIEW; SCREENING; SLEEP DISORDER; SOCIAL INTERACTION; SOCIAL SUPPORT; SPONTANEOUS ABORTION; SUICIDE ATTEMPT; TERATOGENICITY; YOGA;

DEPRESSION; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; MASS SCREENING; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; UNITED STATES;

EID: 70449900988     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2009.10.006     Document Type: Review

References (125)

1. Kessler R.C., Zhao S., Blazer D.G., et al. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 45 (1997) 19
2. Weissman M.M., and Olfson M. Depression in women: implications for health care research. Science 269 (1995) 799
3. Brown M.A., and Solchany J.E. Two overlooked mood disorders in women: subsyndromal depression and prenatal depression. Nurs Clin North Am 39 (2004) 83
4. Gotlib I.H., Whiffen V.E., Mount J.H., et al. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 57 (1989) 269
5. Marcus S.M., Flynn H.A., Blow F.C., et al. Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health (Larchmt) 12 (2003) 373
6. Flynn H.A., O'Mahen H., Massey L., et al. The impact of a brief obstetrics clinic-based intervention on treatment use for perinatal depression. J Womens Health 15 (2006) 1195
7. ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 56 (1997) 279
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition (1994), American Psychiatric Association, Washington, DC
9. Ross L., and McLean L. Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry 67 (2006) 1285
10. Kumar R., and Robson K.M. A prospective study of emotional disorders in childbearing women. Br J Psychiatry 144 (1984) 35
11. Altshuler L.L., Cohen L.S., Moline M.L., et al. Treatment of depression in women: a summary of the expert consensus guidelines. J Psychiatr Pract 7 3 (2001) 185
12. Westdahl C., Milan S., Magriples U., et al. Social support and social conflict as predictors of prenatal depression. Obstet Gynecol 110 (2007) 134
13. Altshuler L.L., Hendrick V., and Cohen L.S. Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry 59 Suppl 2 (1998) 29
14. USPSTF. Screening for depression: recommendations and rationale. Ann Intern Med 136 (2002) 760
15. Feinman J.A., Cardillo D., Palmer J., et al. Development of a model for the detection and treatment of depression in primary care. Psychiatr Q 71 (2000) 59
16. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1 (1977) 385
17. Cox J.L., Holden J.M., and Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150 (1987) 782
18. Jardri R., Pelta J., Maron M., et al. Predictive validation study of the Edinburgh Postnatal Depression Scale in the first week after delivery and risk analysis for postnatal depression. J Affect Disord 93 (2006) 169
19. Matthey S., Henshaw C., Elliott S., et al. Variability in use of cut-off scores and formats on the Edinburgh Postnatal Depression Scale: implications for clinical and research practice. Arch Womens Ment Health 9 (2006) 309
20. Ross A.S., Hall R.W., Frost K., et al. Antenatal & neonatal guidelines, education & learning system. J Ark Med Soc 102 (2006) 328
21. Muzik M., Klier C.M., Rosenblum K.L., et al. Are commonly used self-report inventories suitable for screening postpartum depression and anxiety disorders?. Acta Psychiatr Scand 102 (2000) 71
22. Katon W.J., and Seelig M. Population-based care of depression: team care approaches to improving outcomes. J Occup Environ Med 50 (2008) 459
23. Gilbody S., Bower P., Fletcher J., et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 166 (2006) 2314
24. Flynn HA, Henshaw E, O'Mahen HA. et al. Patient perspectives on improving the depression referral processes in obstetrics settings: a qualitative study. General Hospital Psychiatry, in press.
25. Zuckerman B., Amaro H., Bauchner H., et al. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet Gynecol 160 (1989) 1107
26. Chung T.K., Lau T.K., Yip A.S., et al. Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med 63 (2001) 830
27. Wadhwa P.D., Sandman C.A., Porto M., et al. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am J Obstet Gynecol 169 (1993) 858
28. Zuckerman B., Bauchner H., Parker S., et al. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 11 (1990) 190-194
29. Teixeira J.M., Fisk N.M., and Glover V. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. BMJ 318 (1999) 153
30. Wadhwa P.D., Dunkel-Schetter C., Chicz-DeMet A., et al. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom Med 58 (1996) 432
31. Hoffman S., and Hatch M.C. Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol 19 (2000) 535
32. ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists number 92. Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 111 4 (2008) 1001-1020
33. Heringhausen J, Marcus S, Muzik M, et al. Neonatal sleep patterns and relationship to maternal depression. In: Poster Presentation American Academy of Child & Adolescent Psychiatry Annual Meeting. Chicago, October 28-November 2, 2008.
34. Coghill S.R., Caplan H.L., Alexandra H., et al. Impact of maternal postnatal depression on cognitive development of young children. Br Med J 292 (1986) 1165
35. Forman D.R., O'Hara M.W., Stuart S., et al. Effective treatment for postpartum depression is not sufficient to improve the developing mother-child relationship. Dev Psychopathol 19 (2007) 585
36. Alpern L., and Lyons-Ruth K. Preschool children at social risk. Chronicity and timing of maternal depressive symptoms and child behavior at school and at home. Dev Psychopathol 5 (1993) 371
37. Bifulco A., Figueiredo B., Guedeney N., et al. Maternal attachment style and depression associated with childbirth: preliminary results from a European and US cross-cultural study. Br J Psychiatry 184 (2004) 31
38. Field T. Infants of depressed mothers. Infant Behav Dev 18 (1995) 1
39. Essex M.J., Klein M.H., Cho E., et al. Maternal stress beginning in infancy may sensitize children to later stress exposure: effects on cortisol and behavior. Biol Psychiatry 52 (2001) 776
40. Lyons-Ruth K., Wolfe R., and Lyubchik A. Depression and the parenting of young children: making the case for early preventive mental health services. Harv Rev Psychiatry 8 (2000) 148
41. Weissman M.M., Prusoff B.A., Gammon G.D., et al. Psychopathology in the children (ages 6-18) of depressed and normal parents. J Am Acad Child Psychiatry 23 (1984) 78
42. Einarson A, Miropolsky V, Varma B, et al. Determinates of physicians' decision-making regarding the prescribing of antidepressant medication during pregnancy. In: Fifteenth International Conference of the Organization of Teratology Information Services (OTIS). Scottsdale (AZ), June 22, 2008
43. Gonsalves L., and Schuermeyer I. Treating depression in pregnancy: practical suggestions. Cleve Clin J Med 73 (2006) 1098
44. Hostetter A., Stowe Z.N., Strader J.R.J., et al. Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. Depress Anxiety 11 (2000) 51
45. Cohen L.S., Altshuler L.L., Harlow B.L., et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295 (2006) 499
46. Hostetter A., Richie J.C., and Stowe Z.N. Amniotic fluid and umbilical cord blood concentrations of antidepressants in 3 women. Biol Psychiatry 48 (2000) 1032
47. Hemels M.E., Einarson A., Koren G., et al. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 39 (2005) 803
48. Chun-Fai-Chan B., Koren G., Fayez I., et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 192 (2005) 932
49. Einarson A., Choi J., Einarson T., et al. Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can 31 (2009) 452
50. Einarson A. Risks/safety of psychotropic medication use during pregnancy. Can J Clin Pharmacol 16 (2009) 58
51. GlaxoSmithKline. Available at: http://www.gsk.com/media/paroxetine_pregnancy.htm. Accessed October 18, 2009.
52. Einarson A., Pistelli A., DeSantis M., et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 165 (2008) 749
53. Alwan S., Reefhuis J., Rasmussen S.A., et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356 (2007) 2684
54. Louik C., Lin A.E., Werler M.M., et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356 (2007) 2675
55. Koren G., Matsui D., Einarson A., et al. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?. CMAJ 172 (2005) 1457
56. Boucher N., Bairam A., and Beaulac-Baillargeon L. A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy. J Clin Psychopharmacol 28 (2008)
57. Ferreira E., Carceller A.M., Agogue C., et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 119 (2007) 52
58. Moses-Kolko E.L., Bogen D., Perel J., et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293 (2005) 2372
59. Chambers C.D., Johnson K.A., Dick L.M., et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335 (1996) 1010
60. Kallen B., and Olausson P.O. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 17 (2008) 801
61. Chambers C.D., Hernandez-Diaz S., Van Marter L.J., et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354 (2006) 579
62. Boucher N., Koren G., and Beaulac-Baillargeon L. Maternal use of venlafaxine near term: correlation between neonatal effects and plasma concentrations. Ther Drug Monit 31 (2009) 404
63. Oberlander T.F., Warburton W., Misre S., et al. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry 192 (2008) 338
64. Einarson A., Selby P., Koren G., et al. Abrupt discontinuation of psychotropic drugs during pregnancy: dilemmas and guidelines. Am J Psychiatry 26 (2001) 44
65. Altshuler L.L., Cohen L.S., Szuba M.P., et al. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153 (1996) 592
66. Sharma V. A cautionary note on the use of antidepressants in postpartum depression. Bipolar Disord 8 (2006) 411
67. Schimmell M.S., Katz E.Z., Shaag Y., et al. Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 29 (1991) 479
68. Nulman I., Rovet J., Stewart D.E., et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336 (1997) 258
69. Einarson T.R., and Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 14 (2005) 823
70. Way C.M. Safety of newer antidepressants in pregnancy. Pharmacotherapy 27 (2007) 546
71. O'Hara M.W., Stuart S., Gorman L.L., et al. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 57 (2000) 1039
72. Bhatia S.C., and Bhatia S.K. Depression in women: diagnostic and treatment considerations. Am Fam Physician 60 (1999) 225
73. Daley A.J., Macarthur C., WInter H., et al. The role of exercise in treating postpartum depression: a review of the literature. J Midwifery Womens Health 52 (2007) 56
74. Freeman M.P., Hibbeln J.R., Wisner K.L., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67 (1954) 2006
75. Beddoe A.E., and Lee K.A. Mind-body interventions during pregnancy. J Obstet Gynecol Neonatal Nurs 37 (2008) 165
76. Beddoe A.E., Yang C.P., Kennedy H.P., et al. The effects of mindfulness-based yoga during pregnancy on maternal psychological and physical distress. J Obstet Gynecol Neonatal Nurs 38 (2009) 310
77. Anderson E.L., and Reti I.M. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med 71 (2009) 235
78. Miller L.J. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 45 (1994) 444
79. Steiner M. Perinatal mood disorders: position paper. Psychopharmacol Bull 34 (1998) 301
80. Hobfoll S.E., Ritter C., Lavin J., et al. Depression prevalence and incidence among inner-city pregnant and postpartum women. J Consult Clin Psychol 63 (1995) 445
81. Logsdon M.C., and Usui W. Psychosocial predictors of postpartum depression in diverse groups of women. West J Nurs Res 23 (2001) 563
82. Secco M.L., Profit S., Kennedy E., et al. Factors affecting postpartum depressive symptoms of adolescent mothers. J Obstet Gynecol Neonatal Nurs 36 (2007) 47
83. Shanok A.F., and Miller L. Depression and treatment with inner-city pregnant and parenting teens. Arch Womens Ment Health 10 (2007) 199
84. Klier C.M., Rosenblum K.L., Zeller M., et al. A multi-risk approach to predicting chronicity of postpartum depression symptoms. Depress Anxiety 25 (2008) 718
85. Epperson C.N. Post-partum major depression: detection and treatment. Am Fam Physician 59 (1999) 2247
86. Wisner K.L., Parry B.L., Piontek C.M., et al. Clinical practice. Postpartum depression. N Engl J Med 347 (2002) 194
87. Kendell R., Chalmers J.C., and Platz C. Epidemiology of puerpereal psychoses. Br J Psychiatry 150 (1987) 662
88. O'Hara M.W., and Swain A.M. Rates and risk of post-partum depression-a meta-analysis. Int Rev Psychiatry 8 (1996) 37
89. Hannah P., Adams D., Lee A., et al. Links between early post-partum mood and post-natal depression. Br J Psychiatry 160 (1992) 777
90. Harlow B.L., Vitonis A.F., Sparen P., et al. Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. Arch Gen Psychiatry 64 (2007) 42
91. Cohen L.S. Treatment of bipolar disorder during pregnancy. J Clin Psychiatry 68 Suppl 9 (2007) 4
92. Milgrom J., Gemmill A.W., Bilszta J.L., et al. Antenatal risk factors for post-natal depression: a large prospective study. J Affect Disord 108 (2008) 147
93. Cooper P.J., and Murray L. Course and recurrence of post-natal depression. Evidence for the specificity of the diagnostic concept. Br J Psychiatry 166 (1995) 191
94. Wisner K.L., Perel J., Peindl K.S., et al. Prevention of recurrent post-partum depression: a randomized clinical trial. J Clin Psychiatry 62 (2001) 82
95. Bloch M., Schmidt P.J., Danaseau M., et al. Effects of gonadal steroids in women with a history of post-partum depression. Am J Psychiatry 157 (2000) 924
96. Wisner K.L., and Stowe Z.N. Psychobiology of post-partum mood disorders. Semin Reprod Endocrinol 15 (1997) 77
97. Gjerdingen D.K., and Yawn B.P. Post-partum depression screening: importance, methods, barriers, and recommendations for practice. J Am Board Fam Med 20 (2007) 280
98. Flynn H.A., Blow F.C., and Marcus S.M. Rates and predictors of depression treatment among pregnant women in hospital-affiliated obstetrics practices. Gen Hosp Psychiatry 28 (2006) 289
99. Cohen L.S., Viguera A.C., Bouffard S.M., et al. Venlaflaxine in the treatment of post-partum depression. J Clin Psychiatry 62 (2001) 592
100. Wisner K.L., Peindl K.S., Gigliotti T.V., et al. Tricyclics vs. SSRIs for post-partum depression. Arch Womens Ment Health 1 (1999) 189
101. Wisner K.L., Perel J., Peindl K.S., et al. Effects of the post-partum period on nortriptyline pharmacokinetics. Psychopharmacol Bull 33 (1997) 243
102. Stowe Z.N., Owens M.J., Landry J.C., et al. Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 154 (1997) 1255
103. Spigset O., Carleborg L., Norstrom A., et al. Peroxetine level in breast milk. J Clin Psychiatry 57 (1996) 39
104. Kristensen J.H., Ilett K.F., Hackett L.P., et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 48 (1999) 521
105. Lester B.M., Cucca J., Andreozzi L., et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 32 (1993) 1253
106. Yoshida K., Smith B., Craggs M., et al. Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affect Disord 43 (1997) 225
107. Hale T.W. Drug therapy and breast-feeding: anti-depressants, anti-psychotics, anti-manics, and sedatives. Neo Reviews 5 (2004) E451
108. Kristensen J.H., Ilett K.F., Rampono J., et al. Transfer of the anti-depressant mirtazapine into breast milk. Br J Clin Pharmacol 63 (2007) 322
109. Verbeeck R.K., Ross S.G., McKenna E.A., et al. Excretion of trazodone in breast milk. Br J Clin Pharmacol 22 (1986) 367
110. Yapp P., Ilett K.F., Kristensen J.H., et al. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites. Ann Pharmacother 34 (2000) 1269
111. Chaudron L.H., and Schoenecker C.J. Bupropion and breastfeeding: a case of a possible infant seizure. J Clin Psychiatry 65 (2004) 881
112. Ringdahl E.N., Pereira S.L., Delzell J.E., et al. Treatment of primary insomnia. J Am Board Fam Pract 17 (2004) 212
113. Summerfield R.J., and Nielsen M.S. Excretion of lorazepam into breast milk. Br J Anaesth 57 (1985) 1042
114. Johnstone M.J. The effect of lorazepam on neonatal feeding behaviour at term. Pharmatherapeutica 3 (1982) 259
115. Milgrom J., Negri L.M., Gemmill A.W., et al. A randomized controlled trial of psychological interventions for post-natal depression. Br J Clin Psychol 44 (2005) 529
116. Flynn H.A., Henshaw E., O'Mahen H., et al. Personalizing CBT for perinatal depression: results of a qualitative study on improving intervention engagement and effectiveness (2008), Team UofMDoPP, Ann Arbor (MI)
117. Gay C.L., Lee K.A., Lee S.Y., et al. Sleep patterns and fatigue in new mothers and fathers. Biol Res Nurs 5 (2004) 311
118. Cohen N.J., Muir E., Lojkasek M., et al. Watch, wait, and wonder: testing the effectiveness of a new approach to mother-infant psychotherapy. Infant Ment Health J 20 (1999) 429
119. Fraiberg S., Edelson E., and Shapiro V. Ghosts in the nursery. A psychoanalytic approach to the problems of impaired infant-mother relationships. In: Fraiberg L. (Ed). Selected writings of Selma Fraiberg (1987), Ohio State University Press, Columbus (OH) 100-136
120. Field T., Grizzle N., Scafidi F., et al. Massage therapy for infants of depressed mothers. Infant Behav Dev 19 (1996) 107
121. Field T., Pickens J., Prodromidis M., et al. Targeting adolescent mothers with depressive symptoms for early intervention. Adolescence 35 (2000) 381
122. In: Cicchetti D., and Cohen D. (Eds). Attachment and developmental psychopathology. (Developmental psychopathology) (2006), John Wiley & Sons, New Jersey 207-226
123. Clark R., Tluczek A., and Wenzel A. Psychotherapy for postpartum depression: a preliminary report. Am J Orthopsychiatry 73 (2003) 441
124. Gregoire A.J., Kumar R., Everitt B., et al. Transdermal oestrogen for treatment of severe post-natal depression. Lancet 347 (1996) 930
125. Lawrie T.A., Hofmeyr G.J., De Jager M., et al. A double-blind randomised placebo controlled trial post-natal norethisterone enanthate: the effect on post-natal depression and serum hormones. Br J Obstet Gynaecol 105 (1998) 1082